AUDIO SUMMARY

The therapeutic effectiveness of oral cannabidiol in addition to current treatment in cats with osteoarthritis

Oliver Wilkinson, BSc (Hons), BVSc MRCVS1*


1 University of Bristol Veterinary School, United Kingdom
* Corresponding author email: oliver.wilkinson7@gmail.com

Published: 11 Jun 2025

DOI: https://doi.org/10.18849/ve.v9i4.691

In this audio summary, Oliver Wilkinson asks, in cats with osteoarthritis, does the oral supplementation of cannabidiol (CBD) oil, compared to conventional treatment alone, improve treatment outcomes of reducing pain and improving locomotion? Read the full Knowledge Summary here. 

Audio Summaries are a free resource that enable vets and vet nurses to more quickly and more easily access and digest relevant and up-to-date evidence! A time-saving way to make better and faster evidence-based decisions.

Audio Summary Transcript

My name is Oliver Wilkinson, a final year student at the University of Bristol. I chose the question, ‘In cats with osteoarthritis, does oral supplementation of CBD oil, compared to conventional treatment alone, improve treatment outcomes of reducing pain and improving locomotion?’. This was chosen to follow on from a piece of Knowledge Summary coursework I completed in fourth year, and now I feel this is a very relevant topic currently with the rise of cannabis legalisation in other countries, and the increasing popularity of CBD in the human market in the UK as an alternative.

My research found some peer review studies into the effects of CBD have been done in dogs, however there aren't any in cats that presented data linking CBD with analgesia for osteoarthritis. The two most relevant papers were excluded due to small sample size and subjective results, and a case study with other comorbidities was also using other proven methods of analgesia, making it a poor candidate to assess the effects of CBD.

Whilst I did find as part of my research that there is weak evidence for the effectiveness of CBD in dogs, the conclusion is that more high-quality randomised controlled studies are needed, especially in cats, where very little species-specific research has been done.

Intellectual Property Rights

Authors of Knowledge Summaries submitted to RCVS Knowledge for publication will retain copyright in their work, and will be required to grant to RCVS Knowledge a non-exclusive licence to publish including but not limited to the right to publish, re-publish, transmit, sell, distribute and otherwise use the materials in all languages and all media throughout the world, and to licence or permit others to do so.

Disclaimer

Knowledge Summaries are a peer-reviewed article type which aims to answer a clinical question based on the best available current evidence. It does not override the responsibility of the practitioner. Informed decisions should be made by considering such factors as individual clinical expertise and judgement along with patient’s circumstances and owners’ values. Knowledge Summaries are a resource to help inform and any opinions expressed within the Knowledge Summaries are the author's own and do not necessarily reflect the view of the RCVS Knowledge. Authors are responsible for the accuracy of the content. While the Editor and Publisher believe that all content herein are in accord with current recommendations and practice at the time of publication, they accept no legal responsibility for any errors or omissions, and make no warranty, express or implied, with respect to material contained within. For further information please refer to our Terms of Use.



Open Access